NAD+ precursors: Hong Kong, ANZ and China help drive Chromadex results as firm fires warning over NMN explosion
Nicotinamide riboside (NR) supplement specialist Chromadex’s has posted strong regional and global FY2020 financials, but the firm has issued a warning of ‘concerning behaviour’ from some nicotinamide mononucleotide (NMN) brands, especially in China.